The unethicality of doping in sports.


Journal

La Clinica terapeutica
ISSN: 1972-6007
Titre abrégé: Clin Ter
Pays: Italy
ID NLM: 0372604

Informations de publication

Date de publication:
Historique:
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 14 6 2019
Statut: ppublish

Résumé

Performance enhancing drug use in sport arguably constitutes a crisis, and as such, targeted measures are needed in order to stem it. Substance abuse in professional sports and competitions has besmirched many world-class athletes' reputations and standing, in addition to jeopardizing their health. Furthermore, there are many instances of amateur athletes and school-aged competitors who have taken to using such substances as well, significantly exacerbating the overall picture. The widespread acknowledgement of the potentially life-threatening consequences of performance-enhancing drug use has prodded sports organizations and governments into cooperating on many different levels to preserve the ethical grounding and soundness of sport competitions; unlawful substance abuse is in fact liable to undermine the very core of fairness in competition. Doping, along with various forms of cheating, has been recorded throughout the history of sport: prohibition in itself is all but ineffective without reliable and systematic detection strategies and enforcement of sanctions.

Identifiants

pubmed: 30993304
doi: 10.7417/CT.2019.2117
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e100-e101

Auteurs

I Palmi (I)

Centro Nazionale Dipendenze e Doping, Istituto Superiore di Sanità, Roma.

P Berretta (P)

Centro Nazionale Dipendenze e Doping, Istituto Superiore di Sanità, Roma.

A Tini (A)

Unit of Forensic Toxicology (UoFT), Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Rome.

G Ricci (G)

School of Law, University of Camerino, Camerino, Italy.

S Marinelli (S)

School of Law, University of Camerino, Camerino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH